Search Results - "Tutt, A.L."
-
1
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects
Published in Journal of immunological methods (31-08-2010)“…Rituximab is a chimeric anti-CD20 monoclonal antibody that has revolutionised the treatment of many B-cell malignancies, and is now increasingly being used in…”
Get full text
Journal Article -
2
Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum
Published in Journal of immunological methods (15-12-2010)“…As part of a Phase I chimeric anti-CD40 monoclonal antibody clinical trial, two enzyme-linked immunosorbent assays (ELISAs) were developed for secondary…”
Get full text
Journal Article -
3
Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin
Published in The Lancet (British edition) (22-07-1995)“…We report the use of a bispecific F(ab')2 antibody to target the ribosome-inactivating protein saporin to the surface antigen CD22 in the treatment of…”
Get more information
Journal Article -
4
Response of B-cell lymphoma to a combination of bispecific antibodies and saporin
Published in Leukemia research (01-07-1996)“…Observations are described using a combination of two bispecific F(ab′) 2 antibodies (BsAb) to deliver the ribosome-inactivating protein, saporin, in the…”
Get full text
Journal Article -
5
Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors
Published in Molecular immunology (01-11-1991)“…Fc gamma RII (CDw32) on monocytes is capable of triggering both phagocytosis and lysis of chick red blood cells (CRBC) coated with antibody of the appropriate…”
Get more information
Journal Article -
6
Monoclonal Anti-Light Chain Idiotype as a Tumor-Specific Probe for Human Neoplastic B Lymphocytes
Published in Blood (01-03-1987)“…Tumor cells from patients with B cell neoplasms often secrete small amounts of free monoclonal light chains that can be found in the urine. Such tumor-derived…”
Get full text
Journal Article